Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IPN60090 is a novel, potent, orally bioavailable, renal-type glutaminase (GLS1)-specific inhibitor with an IC50 value of 31 nM for GLS1. IPN60090 has potential anticancer and immunostimulant/immunomodulatory activity, selectively targets, binds, and inhibits human glutaminase, and can be used to study GLS1-mediated diseases.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 33,500 | |||
5 mg | 在庫あり | ¥ 83,500 | |||
10 mg | 在庫あり | ¥ 129,500 | |||
25 mg | 在庫あり | ¥ 204,500 | |||
50 mg | 在庫あり | ¥ 282,500 | |||
100 mg | 在庫あり | ¥ 383,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 98,000 |
ターゲット&IC50 | GLS1:31 nM (IC50) |
別名 | GLS1-IN-1 |
分子量 | 532.52 |
分子式 | C24H27F3N8O3 |
CAS No. | 1853164-83-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (51.64 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IPN60090 1853164-83-6 Metabolism Others transporter IPN-60090 IPN 60090 GLS1-IN-1 Inhibitor inhibitor inhibit